
北美细胞外基质市场预测至 2028 年 - COVID-19 按原材料(牛、猪和其他原材料)、应用(软组织修复、硬脑膜修复、伤口愈合、心脏修复、心包修复和血管)的影响和区域分析修复和重建)
No. of Pages: 130 | Report Code: TIPRE00027064 | Category: Life Sciences
No. of Pages: 130 | Report Code: TIPRE00027064 | Category: Life Sciences
市场介绍
由蛋白质和其他分子组成的大型网络,围绕、支持和赋予体内细胞和组织结构。细胞外基质帮助细胞附着到附近的细胞并与其通信,并在细胞生长、细胞运动和其他细胞功能中发挥重要作用。细胞外基质还参与修复受损组织。细胞外基质的异常变化可能导致某些疾病的发生,例如癌症。
此外,外伤和心血管疾病的发生率增加以及血管重建手术的增加。然而,脱细胞细胞外基质使用过程中的挑战预计将限制预测期内的市场增长。
美国登记的因 COVID-19 导致的死亡人数最高大流行。各国医疗行业出现混乱局面,医院对诊断和治疗设备的需求急剧增加。例如,该地区各国医院对呼吸机、呼吸器和体外诊断(IVD)测试的需求急剧增加。 FDA 加大了支持人们健康的力度,并对医院和医疗器械公司实施了多项指导方针。多家公司还加强了诊断测试和治疗设备的研发活动。尽管医疗保健行业在过去几年中经历了 SARS、H1N1 和其他疫情,但 COVID-19 的严重性因其传播方式而使情况变得更加复杂。自爆发以来,北美的 COVID-19 病例数量不断增加。
< u>市场概况和动态
北美细胞外基质市场预计到 2028 年将从 12,163.1 万美元增至 20,111.6 万美元。 2021 年。预计 2021 年至 2028 年市场复合年增长率为 7.4%。发展中国家正在显着改善其医疗设施和服务,并正在迈向技术进步。随着制造成本不断增加,医疗器械制造商正在努力赚取足够的收入来取悦投资者。这些经济体正在针对细胞外基质举办大量会议和研究活动。发展中经济体的新兴市场预计将为领先企业扩大业务和地理覆盖范围提供更好、更有利可图的增长机会。一些新兴国家正在大力投资医疗保健行业的生物技术领域的开发。该市场正在整合多家从事生物技术领域各种技术研发的本地和跨国企业。因此,由于上述因素,市场在预测期内可能会出现显着的增长机会。
主要细分市场
就原材料而言,猪细分市场在2020年北美细胞外基质市场中占据最大份额。从应用来看,2020年软组织修复领域占据北美细胞外基质市场最大份额。
< u>主要来源和上市公司
准备本北美细胞外基质市场报告时参考的一些主要一手和二手来源包括公司网站、年报、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括美敦力 (Medtronic)、默克 Kgaa、Mtf Biologics、施乐辉 (Smith & Nephew)、Anteris、Aziyo、康乐保集团 (Coloplast Group)、百特 (Baxter)、帝斯曼 (DSM) 和库克生物科技 (Cook Biotech)。
< /span>
购买报告的理由
< /p>
北美细胞外基质市场细分
按原料
作者应用
按国家/地区
< /strong>
提及的公司
Strategic insights for North America Extracellular Matrix involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 12,163.1 thousand |
Market Size by 2028 | US$ 20,111.6 thousand |
Global CAGR (2021 - 2028) | 7.4% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 原料
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Extracellular Matrix refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Extracellular Matrix Market is valued at US$ 12,163.1 thousand in 2021, it is projected to reach US$ 20,111.6 thousand by 2028.
As per our report North America Extracellular Matrix Market, the market size is valued at US$ 12,163.1 thousand in 2021, projecting it to reach US$ 20,111.6 thousand by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.
The North America Extracellular Matrix Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Extracellular Matrix Market report:
The North America Extracellular Matrix Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Extracellular Matrix Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Extracellular Matrix Market value chain can benefit from the information contained in a comprehensive market report.